Vascular Neurology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
China National Clinical Research Center for Neurological Diseases, Beijing, China.
Stroke Vasc Neurol. 2019 May 12;4(3):165-170. doi: 10.1136/svn-2019-000233. eCollection 2019 Sep.
In 2009, China launched ambitious healthcare reform plans to provide affordable and equitable basic healthcare for all patients, including the substantial number of patients who had a stroke. However, little is known about the pattern of evidence-based stroke care and outcomes across hospitals, regions and time during the last decade.
The Patient-centered Retrospective Observation of Guideline-Recommended Execution for Stroke Sufferers in China (China PROGRESS) Study aims to use findings from a representative sample of Chinese hospitals over the last decade to improve future stroke care for patients hospitalised with ischaemic stroke (IS) or transient ischaemic attack (TIA).
The China PROGRESS Study will use a two-stage cluster sampling method to identify over 32000 patient records from 208 hospitals across the Eastern, Central and Western geographical regions in China. To assess the temporal trends in patient characteristics, treatment and outcomes, study investigators will select records from 2005, 2010 and 2015. A double data reading/entry system will be developed to conduct this assessment. A central coordinating centre will monitor case ascertainment, data abstraction and data management. Analyses will examine patient characteristics, testing patterns, in-hospital treatment and outcomes, and variations across regions and across time.
The China PROGRESS Study is the first nationally representative study that aims to better understand care quality and outcomes for patients with IS or TIA before and after the national healthcare reform in China. This initiative will translate findings into clinical practices that improve care quality for patients who had a stroke and policy recommendations that allow these changes to be implemented widely. This study has also been approved by the central institutional review board (IRB) at Beijing Tiantan Hospital.
2009 年，中国启动了雄心勃勃的医疗改革计划，旨在为包括大量脑卒中患者在内的所有患者提供负担得起且公平的基本医疗服务。然而，过去十年中，关于医院、地区和时间之间基于证据的脑卒中治疗模式和结果的信息知之甚少。
以患者为中心的中国脑卒中患者指南推荐执行情况回顾性观察研究（China PROGRESS）旨在利用过去十年中国代表性医院的发现，改善未来脑卒中患者的住院治疗效果，这些患者患有缺血性脑卒中（IS）或短暂性脑缺血发作（TIA）。
China PROGRESS 研究将采用两阶段聚类抽样方法，从中国东部、中部和西部地理区域的 208 家医院中确定超过 32000 例患者的病历。为了评估患者特征、治疗和结局的时间趋势，研究人员将从 2005 年、2010 年和 2015 年选择病历。将开发一个双重数据读取/录入系统来进行此评估。一个中央协调中心将监测病例确定、数据提取和数据管理。分析将检查患者特征、检查模式、院内治疗和结局以及地区和时间上的差异。
China PROGRESS 研究是第一项全国代表性研究，旨在更好地了解中国国家医疗改革前后 IS 或 TIA 患者的护理质量和结局。该倡议将把研究结果转化为临床实践，以提高脑卒中患者的护理质量，并提出政策建议，使这些改变得到广泛实施。该研究已获得北京天坛医院中央机构审查委员会（IRB）的批准。
